<?xml version="1.0" encoding="UTF-8"?>
<p>The World Health Organization does not recommend the use of steroids because they could inhibit viral clearance and prolongate viremia (
 <xref rid="B48" ref-type="bibr">48</xref>). Stockman et al. (
 <xref rid="B120" ref-type="bibr">120</xref>) analyzed treatments used during the SARS outbreak of 2002â€“2003. They found that in 29 studies, use of steroids in 25 cases did not detect any efficacy and in 4 cases steroids could be harmful presenting side effects like delayed viral clearance, avascular necrosis, diabetes, and psychosis (
 <xref rid="B33" ref-type="bibr">33</xref>, 
 <xref rid="B120" ref-type="bibr">120</xref>). Therefore, systemic use of glucocorticoids need to be cautiously pursued (
 <xref rid="B31" ref-type="bibr">31</xref>). In a study of 548 patients with severe disease treated with high-dose corticosteroids, patients had an increased death rate than those not treated with corticosteroids (
 <xref rid="B93" ref-type="bibr">93</xref>). Some trials are exploring the effectiveness and safety of glucocorticoids in the treatment of COVID-19.
</p>
